|
2025
|
Invention
|
Isoquinolinones as modulators of polrmt.
The present invention provides novel isoquinolinone com... |
|
|
Invention
|
Modulators of mitochondrial dna replication. The present invention provides novel DNA polymerase ... |
|
2024
|
Invention
|
Oligonucleotides targeting samhd1. Oligonucleotides and their use in modulating (e.g., inhibiting... |
|
|
Invention
|
Compositions and inhibitors of polrmt. The present invention provides novel oxadiazole compounds ... |
|
|
Invention
|
Modulators of mitochondrial dna replication. The present disclosure provides compounds of Formula... |
|
2023
|
Invention
|
Modulators of mitochondrial dna replication. The present invention provides novel sulfonamide com... |
|
|
Invention
|
Compositions and methods for treatment of cancer and metabolic disease. Oligonucleotide compositi... |
|
|
Invention
|
Compositions and methods for treatment of cancer and metabolic disease |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of diseases relating to mitochondria... |
|
2022
|
Invention
|
Amino chromen-2-one modulators of polrmt.
The present invention provides novel amino chromen-2-o... |
|
|
Invention
|
Amino chromen-2-one modulators of polrmt. The present invention provides novel amino chromen-2-on... |
|
|
Invention
|
Lonp1 inhibitor compounds, uses and methods.
Disclosed are compounds according to Formula (I) wh... |
|
|
Invention
|
Lonp1 inhibitors, uses and methods.
Disclosed are compounds according to Formula (1) and Formula... |
|
|
Invention
|
Amide-containing lonp1 inhibitor compounds, uses and methods.
Disclosed are compounds according ... |
|
|
Invention
|
Heterocycle-containing lonp1 inhibitor compounds, uses and methods.
Disclosed are compounds acco... |
|
|
Invention
|
Lonp1 inhibitors, uses and methods. Disclosed are compounds according to Formula (1) and Formula ... |
|
|
Invention
|
Lonp1 inhibitor compounds, uses and methods. Disclosed are compounds according to Formula (I) whi... |
|
|
Invention
|
Heterocycle-containing lonp1 inhibitor compounds, uses and methods. Disclosed are compounds accor... |
|
|
Invention
|
Amide-containing lonp1 inhibitor compounds, uses and methods. Disclosed are compounds according t... |
|
|
Invention
|
Chromen-2-one modulators of polrmt.
The present invention provides novel chromen-2-one compounds... |
|
|
Invention
|
Isoquinolinones and quinolinones as modulators of polrmt.
The present invention provides novel i... |
|
|
Invention
|
Hydroxy and alkoxy coumarins as modulators of polrmt.
The present invention provides novel hydro... |
|
|
Invention
|
Hydroxy and alkoxy coumarins as modulators of polrmt. The present invention provides novel hydrox... |
|
|
Invention
|
Chromen-2-one modulators of polrmt. The present invention provides novel chromen-2-one compounds ... |
|
|
Invention
|
Isoquinolinones and quinolinones as modulators of polrmt. The present invention provides novel is... |
|
2021
|
P/S
|
Engineered proteins and biopharmaceutical preparations and
substances for the treatment of disea... |
|
|
P/S
|
Biopharmaceutical preparations for the treatment of diseases associated with dysfunctional mitoch... |
|
2020
|
P/S
|
Engineered proteins and biopharmaceutical preparations and substances for the treatment of diseas... |
|
|
P/S
|
Scientific and medical research, analysis and development in the fields of mitochondria, and prev... |
